cyclosporine 1 MG/ML Ophthalmic Solution [Vevye]
cyclosporine
RxCUI: 2639941
What the CMS Formulary Data Shows for cyclosporine 1 MG/ML Ophthalmic Solution [Vevye]
Per the CMS 2026 Part D formulary file, cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] (RxNorm concept RXCUI 2639941, generic name cyclosporine) appears on 1 distinct formulary file spanning 8 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 4 to Tier 4, with a cross-plan average of Tier 4.
Real-world access to cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 492,479 Part D beneficiaries filled cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] in 2023, with total plan-and-beneficiary spending of $1,501,664,198 and an average per-beneficiary annual cost of $3,049.19. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 8
- Coverage rate
- 0.2%
- Tier range
- Tier 4, Non-Preferred
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 492,479
- Total spending
- $1,501,664,198
- Avg per beneficiary
- $3,049.19
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering cyclosporine 1 MG/ML Ophthalmic Solution [Vevye]
8 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Network Health Select (PPO) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $0 | WI |
| Network Health Go (PPO) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $0 | WI |
| Network Health Anywhere (PPO) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $0 | WI |
| Network Health Choice (PPO) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $0 | WI |
| Network Health Zero (PPO) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $0 | WI |
| Network Health Cares (PPO D-SNP) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $21.10 | WI |
| Network Health PlusRx (PPO) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $38.60 | WI |
| Network Health PremierRx (PPO) | NETWORK HEALTH INSURANCE CORPORATION | T4 | No | $92.80 | WI |
Frequently Asked Questions
Is cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] covered by Medicare Part D?
Yes, cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] is covered by 8 Medicare Part D plans (0.2% of all Part D formularies).
What tier is cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] on Medicare Part D plans?
cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] averages Tier 4 across Part D plans, ranging from Tier 4 to Tier 4.
Does cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] require prior authorization?
0% of Part D formularies require prior authorization for cyclosporine 1 MG/ML Ophthalmic Solution [Vevye]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on cyclosporine 1 MG/ML Ophthalmic Solution [Vevye]?
In 2023, total Medicare Part D spending on cyclosporine 1 MG/ML Ophthalmic Solution [Vevye] was $1,501,664,198, covering 492,479 beneficiaries. The average spend per beneficiary was $3,049.19.
Read our methodology - how this data is sourced, computed, and verified.